Mustang Bio, Inc. ( MBIO) - Stock Earnings
MBIO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 18, 2026, midnight | — / — | — | — / — | — |
MBIO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -538000 USD | — USD |
| 2026Q1 | -955000 USD | — USD |
| 2026Q2 | -1.1 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
MBIO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -51.6 million USD | — USD |
| 2024 | -15.8 million USD | — USD |
| 2025 | -1.9 million USD | — USD |
| 2026 Est. | — | — |
MBIO
Price: $0.40
52 week price:
Earnings Per Share: -0.42 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 169948
Ebitda: -6.9 millionMarket Capitalization: 3.4 million